Author:
Selvaraj Vithyalakshmi,Madabushi Jayakrishna S.,Gunasekar Palanikumar,Singh Sanjay P.
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Reference7 articles.
1. Tan TC, de Boer BW, Mitchell A et al (2008) Levetiracetam as a possible cause of fulminant liver failure. Neurology 71(9):685–686
2. Sethi NK, Sethi PK, Torgovnick J, Arsura E, Cukierwar F (2013) Asymptomatic elevation of liver enzymes due to levetiracetam: a case report. Drug Metabol Drug Interact 28(2):123–124
3. Xiong N, Hou L, Lu N, Mohamed AA, Wang T, Huang Y (2012) Probable levetiracetam-related serum alkaline phosphatase elevation. BMC Neurol. 12:97
4. Broli M, Provini F, Naldi I et al (2010) Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. Epileptic Disord 12(1):81–82
5. Gutierrez-Grobe Y, Bahena-Gonzalez JA, Herrera-Gomar M, Mendoza-Diaz P, Garcia-Lopez S, Gonzalez-Chon O (2013) Acute liver failure associated with levetiracetam and lacosamide combination treatment for unspecified epileptic disorder. Case Rep Emerg Med 2013:634174
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献